Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9355)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 28, 2021 (publication date) through Jul 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
Artificial Intelligence in Gastroenterology
ISSN
2644-3236
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kanda T, Sasaki R, Masuzaki R, Moriyama M. Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites. Artif Intell Gastroenterol 2021; 2(1): 1-9 [DOI: 10.35712/aig.v2.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2644-3236/full/v2/i1/1.htm |
| Number | Citing Articles |
| 1 |
Reina Sasaki-Tanaka, Tatsuo Kanda, Takeshi Yokoo, Hiroyuki Abe, Kazunao Hayashi, Akira Sakamaki, Hiroteru Kamimura, Shuji Terai. Hepatitis A and E Viruses Are Important Agents of Acute Severe Hepatitis in Asia: A Narrative Review. Pathogens 2025; 14(5): 454 doi: 10.3390/pathogens14050454
|